International Journal of Hematologic Oncology Q3 Unclaimed
Future Medicine Ltd.
United Kingdom
International Journal of Hematologic Oncology is a journal indexed in SJR in Hematology and Oncology with an H index of 1. It is an CC BY-NC-ND Journal with a Double blind peer review review system, and It has a price of 1273.5 €. The scope of the journal is focused on lymphoma, leukaemia, haematologic oncology, myeloma. It has an SJR impact factor of 0,198 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,198.
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
Price
1273.5 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,198
SJR Impact factor1
H Index0
Total Docs (Last Year)1
Total Docs (3 years)0
Total Refs1
Total Cites (3 years)1
Citable Docs (3 years)0
Cites/Doc (2 years)0.0
Ref/DocOther journals with similar parameters
Advances in Hematology Q3
Clinical Lymphoma, Myeloma and Leukemia Q3
Lymphology Q3
Hematology Q3
Journal of Blood Medicine Q3
Compare this journals
Aims and Scope
Lymphoma
Leukaemia
Haematologic oncology
Myeloma
Comments